More Orthocell Ltd news Orthocell LtdASX: OCC Celgro Positive Safety and Performance in Human Hip Study Sep 5, 2017 at 11:48 PM EDT · Issued by Orthocell Ltd Filed with ASX · Sep 5, 2017 at 11:48 PM EDTOn 6ix: 6ix.com/news/celgro-positive-safety-and-performance-in-human-hip-studyOrthocell Ltd has released a press release. View Attachment6ix hasn’t read this filing yet. Read this filing Orthocell Ltd on 6ix Story so farOrthocell Receives Approval for Human Hip Study Using CelgroMay 4, 2016 Earlier from Orthocell1st Patient Recruited in Ortho-ATI Shoulder Tendon StudySep 4, 2017Preliminary Final ReportAug 31, 2017Ortho-ACI on Australian Register of Therapeutic GoodsMay 29, 2017Ethics Approval Received for Pilot Ortho-ATI Tendon StudyApr 30, 2017Response to ASX QueryApr 10, 2017Later from OrthocellSurgical Specialties Appointed as Exclusive DistributorOct 10, 2017Notice of Annual General Meeting/Proxy FormOct 13, 2017Orthocell Granted CelGro Patent Protection in CanadaOct 15, 2017Orthocell receives R&D tax incentive refundOct 23, 2017Orthocell Receives CE Mark for CelGroNov 8, 2017All Orthocell news releases↗Follow Orthocell into a list and get an email when it puts out news.Follow Orthocell